Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Denmark / NCT03962920
Recruiting Not applicable

Personalized Treatment of Urogenital Cancers Depends on the Microbiome

NCT03962920 · tracked via the Priya Life Science Denmark tracker
Sponsor
Zealand University Hospital
Phase
Not applicable
Started
2020-05-01
Last updated
2024-01-30

Condition(s) studied

Microbial Disease

Investigational drug(s) / intervention(s)

Tigecycline 50 MG →Placebo

Tigecycline 50 MG: Local instillation of drug directly to the tumour tissue

Placebo: Local instillation of sterile water directly to the tumour tissue

Study summary

This is a randomized controlled trial where patients undergoing surgical treatment for urogenital cancers will be randomized in a two arms study: surgical treatment + antibiotics OR surgical treatment + placebo.

Eligibility

Sex
ALL
Min age
40 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria: * Biopsy verified diagnosis of urological cancer, localized disease Exclusion Criteria: * Hospitalization within three months of surgery * Antibiotics within three months of surgery * Infectious disease, including UTI's within three months of surgery * History of cancers of the genitourinary tract * Diabetes

Primary outcome measure(s)

  • recurrence rate after surgical treatment of tumour — 5 years after treatment
    recurrence rate after surgical treatment of tumour

Trial sites (1)

FacilityCityRegionStatus
Zealand University Hospital Roskilde Denmark Recruiting

More Zealand University Hospital trials in Denmark

Sonoporation and Tumor Microenvironment Response in Colorectal Liver Metastases Recruiting
Improving Genomic Profiling and Reducing Time to Cancer Treatment Via Targeted Use of Endoscopic Ultrasound Enrolling by invitation
Study on the Effect of 40 Hz Non-Invasive Light Therapy System Recruiting
The Effect of Salicylate on Platelet Function in CKD (Chronic Kidney Disease) Patients Treated With Aranesp Recruiting
The Danish Bladder Cancer Group 23 Study - A European Study on Cancer in the Upper Urinary Tract Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03962920 on ClinicalTrials.gov ↗ ← All trials in Denmark